AAAAAA

   
Results: 1-25 | 26-45
Results: 1-25/45

Authors: CICARDI M BERGAMASCHINI L CUGNO M BERETTA A ZINGALE LC COLOMBO M AGOSTONI A
Citation: M. Cicardi et al., PATHOGENETIC AND CLINICAL ASPECTS OF C1 INHIBITOR DEFICIENCY, Immunobiology, 199(2), 1998, pp. 366-376

Authors: BERGAMASCHINI L ETTERI M CICARDI M NATALE V BRAMBILLA G TESTONI PA AGOSTONI A
Citation: L. Bergamaschini et al., GENERATION OF C1S-C1INH COMPLEXES IN PLASMA OF PATIENTS UNDERGOING ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY, Molecular immunology, 35(6-7), 1998, pp. 7-7

Authors: BERGAMASCHINI L MIEDICO A CICARDI M COPPOLA R AGOSTONI A
Citation: L. Bergamaschini et al., C4-BP IS CONSUMED DURING ACTIVATION OF COMPLEMENT CLASSICAL PATHWAY, Molecular immunology, 35(6-7), 1998, pp. 8-8

Authors: CICARDI M ZINGALE LC BRISCINI L NISOLI E CARRUBA MO GIOVAGNONI MG BERGAMASCHINI L AGOSTONI A
Citation: M. Cicardi et al., BIOCHEMICAL SIGNS OF PROGRAMMED CELL-DEATH IN RAT WHITE ADIPOCYTES ACUTELY EXPOSED TO SERUM OF PATIENTS WITH PARTIAL LIPODYSTROPHY AND COMPLEMENT ABNORMALITIES, Molecular immunology, 35(6-7), 1998, pp. 9-9

Authors: CICARDI M BERETTA A ZANICHELLI A GRINGERI A AGOSTONI A
Citation: M. Cicardi et al., C1-INHIBITOR FUNCTION AND ANTI-C1-INH AUTOANTIBODIES IN PATIENTS WITHHIV-1 INFECTION, Molecular immunology, 35(6-7), 1998, pp. 10-10

Authors: TOSI M CARUGATI A HERNANDEZ C BOUCONTET L PAPPALARDO E AGOSTONI A CICARDI M
Citation: M. Tosi et al., DE-NOVO C1 INHIBITOR MUTATIONS IN HEREDITARY ANGIOEDEMA, Molecular immunology, 35(6-7), 1998, pp. 303-303

Authors: NUSSBERGER J CUGNO M AMSTUTZ C CICARDI M PELLACANI A AGOSTONI A
Citation: J. Nussberger et al., PLASMA BRADYKININ IN ANGIO-EDEMA, Lancet, 351(9117), 1998, pp. 1693-1697

Authors: GARDINALI M CONCIATO L CAFARO C CROSIGNANI A BATTEZZATI PM AGOSTONI A PODDA M
Citation: M. Gardinali et al., COMPLEMENT-SYSTEM IS NOT ACTIVATED IN PRIMARY BILIARY-CIRRHOSIS, Clinical immunology and immunopathology (Print), 87(3), 1998, pp. 297-303

Authors: CASTELLI R CICARDI M GARDINALI M ZINGALE LC SAVI C MUNARI M AGOSTONI A
Citation: R. Castelli et al., CARDIOPULMONARY BYPASS IN A PATIENT WITH ACQUIRED C1 INHIBITOR DEFICIENCY, International journal of artificial organs, 20(3), 1997, pp. 175-177

Authors: CUGNO M CICARDI M BOTTASSO B COPPOLA R PAONESSA R MANNUCCI PM AGOSTONI A
Citation: M. Cugno et al., GENERATION OF THROMBIN WITH SIGNS OF ACTIVATION OF THE CONTACT AND TISSUE FACTOR COAGULATION PATHWAYS IN C1-INHIBITOR DEFICIENCIES, Thrombosis and haemostasis, 1997, pp. 847-847

Authors: DEFILIPPI F CASTELLI R CICARDI M SOFFREDINI R COLOMBO M AGOSTONI A
Citation: F. Defilippi et al., HGV INFECTION IN PATIENTS WITH C1-INH DEFICIENCY, Thrombosis and haemostasis, 1997, pp. 1847-1847

Authors: CICARDI M BERTI E CAPUTO V RADICE F GARDINALI M AGOSTONI A
Citation: M. Cicardi et al., IDIOPATHIC CAPILLARY LEAK SYNDROME - EVIDENCE OF CD8-POSITIVE LYMPHOCYTES SURROUNDING DAMAGED ENDOTHELIAL-CELLS, Journal of allergy and clinical immunology, 99(3), 1997, pp. 417-419

Authors: CICARDI M CASTELLI R ZINGALE LC AGOSTONI A
Citation: M. Cicardi et al., SIDE-EFFECTS OF LONG-TERM PROPHYLAXIS WITH ATTENUATED ANDROGENS IN HEREDITARY ANGIOEDEMA - COMPARISON OF TREATED AND UNTREATED PATIENTS, Journal of allergy and clinical immunology, 99(2), 1997, pp. 194-196

Authors: BERGAMASCHINI L CANZIANI S CUGNO M PARNETTI L AGOSTONI A
Citation: L. Bergamaschini et al., COMPLEMENT AND CONTACT SYSTEM ACTIVATION IN ALZHEIMERS-DISEASE, Journal of allergy and clinical immunology, 99(1), 1997, pp. 112-112

Authors: CICARDI M BERETTA A GIOFFRE D COLOMBO M DAVIS AE AGOSTONI A
Citation: M. Cicardi et al., ALLOTYPE SPECIFICITY OF ANTI-CL-INHIBITOR AUTOANTIBODIES IN ACQUIRED ANGIOEDEMA, Journal of allergy and clinical immunology, 99(1), 1997, pp. 976-976

Authors: GARDINALI M CICARDI M AGOSTONI A
Citation: M. Gardinali et al., EFFECTS OF RADIOGRAPHIC CONTRAST-MEDIA, Investigative radiology, 32(10), 1997, pp. 648-648

Authors: CUGNO M CICARDI M BOTTASSO B COPPOLA R PAONESSA R MANNUCCI PM AGOSTONI A
Citation: M. Cugno et al., ACTIVATION OF THE COAGULATION CASCADE IN C1-INHIBITOR DEFICIENCIES, Blood, 89(9), 1997, pp. 3213-3218

Authors: CICARDI M BERETTA A COLOMBO M GIOFFRE D CUGNO M AGOSTONI A
Citation: M. Cicardi et al., AUTOANTIBODIES TO C1 INHIBITOR IN ACQUIRED C1 INHIBITOR DEFICIENCY - SIGNIFICANCE OF ASSOCIATED M-COMPONENTS AND AFFINITY CHARACTERISTICS, The FASEB journal, 10(6), 1996, pp. 1892-1892

Authors: CUGNO M CICARDI M COLUCCI M BISIANI G MERLINI PA SPINOLA A PAONESSA R AGOSTONI A
Citation: M. Cugno et al., NON NEUTRALIZING ANTIBODIES TO TISSUE-TYPE PLASMINOGEN-ACTIVATOR IN THE SERUM OF ACUTE MYOCARDIAL-INFARCTION PATIENTS TREATED WITH THE RECOMBINANT PROTEIN, Thrombosis and haemostasis, 76(2), 1996, pp. 234-238

Authors: CUGNO M CICARDI M COPPOLA R AGOSTONI A
Citation: M. Cugno et al., ACTIVATION OF FACTOR-XII AND CLEAVAGE OF HIGH-MOLECULAR-WEIGHT KININOGEN DURING ACUTE ATTACKS IN HEREDITARY AND ACQUIRED CL-INHIBITOR DEFICIENCIES, Immunopharmacology, 33(1-3), 1996, pp. 361-364

Authors: BERGAMASCHINI L SANTANGELO T FARICCIOTTI A CIAVARELLA N MANNUCCI PM AGOSTONI A
Citation: L. Bergamaschini et al., STUDY OF COMPLEMENT-MEDIATED ANAPHYLAXIS IN HUMANS - THE ROLE OF IGG SUBCLASSES (IGG1 AND OR IGG4) IN THE COMPLEMENT-ACTIVATING CAPACITY OFIMMUNE-COMPLEXES/, The Journal of immunology, 156(3), 1996, pp. 1256-1261

Authors: CICARDI M BERETTA A COLOMBO M GIOFFRE D CUGNO M AGOSTONI A
Citation: M. Cicardi et al., RELEVANCE OF LYMPHOPROLIFERATIVE DISORDERS AND OF ANTI-C1 INHIBITOR AUTOANTIBODIES IN ACQUIRED ANGIO-EDEMA, Clinical and experimental immunology, 106(3), 1996, pp. 475-480

Authors: CUGNO M SALERNO F LORENZANO E MANDELLI M PAONESSA R AGOSTONI A
Citation: M. Cugno et al., CLEAVAGE OF HIGH-MOLECULAR-WEIGHT KININOGEN IN ASCITES AND PLASMA OF PATIENTS WITH CIRRHOSIS, Thrombosis and haemostasis, 73(6), 1995, pp. 1408-1408

Authors: GARDINALI M CONCIATO L CAFARO C AGOSTONI A
Citation: M. Gardinali et al., COMPLEMENT-SYSTEM IN CORONARY HEART-DISEASE - A REVIEW, Immunopharmacology, 30(2), 1995, pp. 105-117

Authors: AGOSTONI A
Citation: A. Agostoni, PLACEBO AND EU GUIDELINES, Lancet, 346(8991-2), 1995, pp. 1710-1710
Risultati: 1-25 | 26-45